This study is evaluating a once-weekly self-injection to investigate blood sugar control and weight management in adults living with type 2 diabetes who are overweight or living with obesity (BMI 27 kg/m² or above and not currently taking a GLP-1.
This study is being conducted at our Western Sydney clinic.
Apply Now
This is an expression of interest for upcoming type 2 diabetes studies paratus is conducting. Apply now to be contacted when studies start recruiting.
Paratus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
T: 1300 742 326
